Extracellular vesicles in cardiovascular disease

Circulation Research

Volumn 120, Issue 10, 2017, Pages 1649-1657

  Jansen, Felix ^a   Nickenig, Georg ^a   Werner, Nikos ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

biomarkers; cardiovascular diseases; extracellular vesicles; liquid biopsy

Indexed keywords

ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; NUCLEIC ACID; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DIAGNOSTIC TEST; EPIDEMIOLOGICAL DATA; EXOSOME; GENETIC ENGINEERING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; TARGET TISSUE; TISSUE DISTRIBUTION; BLOOD; CARDIOVASCULAR DISEASES; EXTRACELLULAR SPACE; METABOLISM;

BIOMARKERS; CARDIOVASCULAR DISEASES; EXTRACELLULAR SPACE; EXTRACELLULAR VESICLES; HUMANS; PROGNOSIS;

EID: 85019966695     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.310752     Document Type: Review

References (132)

1. Lee Y, El Andaloussi S, Wood MJ, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012 21 R125 R134. doi: 10.1093/hmg/dds317.
2. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007 9 654 659. doi: 10.1038/ncb1596.
3. Mack M, Kleinschmidt A, Brühl H, Klier C, Nelson PJ, Cihak J, Plachý J, Stangassinger M, Erfle V, Schlöndorff D, Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000 6 769 775. doi: 10.1038/77498.
4. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N, Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood 2011 118 2366 2374. doi: 10.1182/blood-2011-01-330878.
5. Raposo G, Stoorvogel W, Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013 200 373 383. doi: 10.1083/jcb.201211138.
6. Zappulli V, Friis KP, Fitzpatrick Z, Maguire CA, Breakefield XO, Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest 2016 126 1198 1207. doi: 10.1172/JCI81134.
7. Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, Théry C, Wauben MH, Hochberg F, Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013 2. doi: 10.3402/jev.v2i0.20360.
8. van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R, Innovation in detection of microparticles and exosomes. J Thromb Haemost 2013 11 s uppl 1 36 45. doi: 10.1111/jth.12254.
9. Robbins PD, Morelli AE, Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014 14 195 208. doi: 10.1038/nri3622.
10. Robbins PD, Dorronsoro A, Booker CN, Regulation of chronic inflammatory and immune processes by extracellular vesicles. J Clin Invest 2016 126 1173 1180. doi: 10.1172/JCI81131.
11. Colombo M, Raposo G, Théry C, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014 30 255 289. doi: 10.1146/annurev-cellbio-101512-122326.
12. Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR, Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 2014 12 614 627. doi: 10.1111/jth.12554.
13. Sun Y, Xia Z, Shang Z, Sun K, Niu X, Qian L, Fan LY, Cao CX, Xiao H, Facile preparation of salivary extracellular vesicles for cancer proteomics. Sci Rep 2016 6 24669. doi: 10.1038/srep24669.
14. Ranghino A, Dimuccio V, Papadimitriou E, Bussolati B, Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J 2015 8 23 30. doi: 10.1093/ckj/sfu136.
15. Goettsch C, Hutcheson JD, Aikawa M, Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. J Clin Invest 2016 126 1323 1336. doi: 10.1172/JCI80851.
16. Théry C, Cancer: diagnosis by extracellular vesicles. Nature 2015 523 161 162. doi: 10.1038/nature14626.
17. Thompson AG, Gray E, Heman-Ackah SM, Mäger I, Talbot K, Andaloussi SE, Wood MJ, Turner MR, Extracellular vesicles in neurodegenerative disease-pathogenesis to biomarkers. Nat Rev Neurol 2016 12 346 357. doi: 10.1038/nrneurol.2016.68.
18. Turpin D, Truchetet ME, Faustin B, Augusto JF, Contin-Bordes C, Brisson A, Blanco P, Duffau P, Role of extracellular vesicles in autoimmune diseases. Autoimmun Rev 2016 15 174 183. doi: 10.1016/j.autrev.2015.11.004.
19. Loyer X, Vion AC, Tedgui A, Boulanger CM, Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014 114 345 353. doi: 10.1161/CIRCRESAHA.113.300858.
20. Libby P, Ridker PM, Maseri A, Inflammation and atherosclerosis. Circulation 2002 105 1135 1143
21. Libby P, Changing concepts of atherogenesis. J Intern Med 2000 247 349 358
22. Dignat-George F, Boulanger CM, The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011 31 27 33. doi: 10.1161/ATVBAHA.110.218123.
23. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H, Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005 45 1622 1630. doi: 10.1016/j.jacc.2005.02.047.
24. Fleury A, Martinez MC, Le Lay S, Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol 2014 5 370. doi: 10.3389/fimmu.2014.00370.
25. Amabile N, Rautou PE, Tedgui A, Boulanger CM, Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010 36 907 916. doi: 10.1055/s-0030-1267044.
26. Rautou PE, Bresson J, Sainte-Marie Y, Vion AC, Paradis V, Renard JM, Devue C, Heymes C, Letteron P, Elkrief L, Lebrec D, Valla D, Tedgui A, Moreau R, Boulanger CM, Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 2012 143 166 176.e6. doi: 10.1053/j.gastro.2012.03.040.
27. Mause SF, Weber C, Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010 107 1047 1057. doi: 10.1161/CIRCRESAHA.110.226456.
28. Théry C, Ostrowski M, Segura E, Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009 9 581 593. doi: 10.1038/nri2567.
29. Harding CV, Heuser JE, Stahl PD, Exosomes: looking back three decades and into the future. J Cell Biol 2013 200 367 371. doi: 10.1083/jcb.201212113.
30. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM, Microparticles, vascular function, and atherothrombosis. Circ Res 2011 109 593 606. doi: 10.1161/CIRCRESAHA.110.233163.
31. Gaceb A, Martinez MC, Andriantsitohaina R, Extracellular vesicles: new players in cardiovascular diseases. Int J Biochem Cell Biol 2014 50 24 28. doi: 10.1016/j.biocel.2014.01.018.
32. Pfeifer P, Werner N, Jansen F, Role and function of microRNAs in extracellular vesicles in cardiovascular biology. Biomed Res Int 2015 2015 161393. doi: 10.1155/2015/161393.
33. Lawson C, Vicencio JM, Yellon DM, Davidson SM, Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J Endocrinol 2016 228 R57 R71. doi: 10.1530/JOE-15-0201.
34. Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, Ho JE, Shaw SY, Cohen KS, Vasan RS, Tedgui A, Boulanger CM, Wang TJ, Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J 2014 35 2972 2979. doi: 10.1093/eurheartj/ehu153.
35. Walenta K, Schwarz V, Schirmer SH, Kindermann I, Friedrich EB, Solomayer EF, Sliwa K, Labidi S, Hilfiker-Kleiner D, Böhm M, Circulating microparticles as indicators of peripartum cardiomyopathy. Eur Heart J 2012 33 1469 1479. doi: 10.1093/eurheartj/ehr485.
36. Torrano V, Royo F, Peinado H, Loizaga-Iriarte A, Unda M, Falcón-Perez JM, Carracedo A, Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol 2016 29 47 53. doi: 10.1016/j.coph.2016.06.003.
37. Hulsmans M, Holvoet P, MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013 100 7 18. doi: 10.1093/cvr/cvt161.
38. Fleissner F, Goerzig Y, Haverich A, Thum T, Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant 2012 12 289 297. doi: 10.1111/j.1600-6143.2011.03790.x.
39. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M, Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012 93 555 562. doi: 10.1093/cvr/cvr266.
40. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F, Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002 51 2840 2845
41. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK, Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002 106 2442 2447
42. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS, Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003 41 211 217
43. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, Mannarino MR, Capanni M, Velardi A, Mannarino E, Increased ratio of CD31+/CD42-microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006 26 2530 2535. doi: 10.1161/01.ATV.0000243941.72375.15.
44. Schwarz V, Bachelier K, Schirmer SH, Werner C, Laufs U, Böhm M, Red wine prevents the acute negative vascular effects of smoking. Am J Med 2017 130 95 100. doi: 10.1016/j.amjmed.2016.08.025.
45. Finn NA, Eapen D, Manocha P, Al Kassem H, Lassegue B, Ghasemzadeh N, Quyyumi A, Searles CD, Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport. FEBS Lett 2013 587 3456 3463. doi: 10.1016/j.febslet.2013.08.034.
46. Suades R, Padró T, Alonso R, Mata P, Badimon L, High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost 2015 114 1310 1321. doi: 10.1160/TH15-04-0325.
47. Libby P, Sukhova G, Lee RT, Liao JK, Molecular biology of atherosclerosis. Int J Cardiol 1997 62 suppl 2 S23 S29
48. Schächinger V, Britten MB, Zeiher AM, Prognostic impact of coronary vasodilator dysfunction on adverse long-Term outcome of coronary heart disease. Circulation 2000 101 1899 1906
49. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G, Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006 26 112 116. doi: 10.1161/01.ATV.0000191634.13057.15.
50. Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM, Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005 16 3381 3388. doi: 10.1681/ASN.2005050535.
51. Ross R, Atherosclerosis-An inflammatory disease. N Engl J Med 1999 340 115 126. doi: 10.1056/NEJM199901143400207.
52. Chironi G, Simon A, Hugel B, Del Pino M, Gariepy J, Freyssinet JM, Tedgui A, Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 2006 26 2775 2780. doi: 10.1161/01.ATV.0000249639.36915.04.
53. Jayachandran M, Litwiller RD, Owen WG, Heit JA, Behrenbeck T, Mulvagh SL, Araoz PA, Budoff MJ, Harman SM, Miller VM, Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008 295 H931 H938. doi: 10.1152/ajpheart.00193.2008.
54. Christersson C, Lindahl B, Siegbahn A, The composition and daily variation of microparticles in whole blood in stable coronary artery disease. Scand J Clin Lab Invest 2016 76 25 32. doi: 10.3109/00365513.2015.1086928.
55. Sluijter JP, Verhage V, Deddens JC, van den Akker F, Doevendans PA, Microvesicles and exosomes for intracardiac communication. Cardiovasc Res 2014 102 302 311. doi: 10.1093/cvr/cvu022.
56. Augustine D, Ayers LV, Lima E, Newton L, Lewandowski AJ, Davis EF, Ferry B, Leeson P, Dynamic release and clearance of circulating microparticles during cardiac stress. Circ Res 2014 114 109 113. doi: 10.1161/CIRCRESAHA.114.301904.
57. Sinning JM, Jansen F, Hammerstingl C, Meier A, Losch J, Rohwer K, Schmitz T, Paul K, Sedaghat A, Schueler R, Vasa-Nicotera M, Müller C, Nickenig G, Werner N, Circulating microparticles decrease after cardiac stress in patients with significant coronary artery stenosis. Clin Cardiol 2016 39 570 577. doi: 10.1002/clc.22566.
58. Bentzon JF, Otsuka F, Virmani R, Falk E, Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721.
59. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R, Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013 34 719 728. doi: 10.1093/eurheartj/ehs411.
60. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A, Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 841 843
61. Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL, Ferreira A, de Marchena E, Ahn YS, Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004 97 439 446. doi: 10.1016/j.ijcard.2003.10.029.
62. Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, Grunebaum L, Ohlmann P, Freyssinet JM, Bareiss P, Toti F, Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009 204 636 641. doi: 10.1016/j.atherosclerosis.2008.10.039.
63. Giannopoulos G, Oudatzis G, Paterakis G, Synetos A, Tampaki E, Bouras G, Hahalis G, Alexopoulos D, Tousoulis D, Cleman MW, Stefanadis C, Deftereos S, Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty. Int J Cardiol 2014 176 145 150. doi: 10.1016/j.ijcard.2014.07.022.
64. Sarlon-Bartoli G, Bennis Y, Lacroix R, Piercecchi-Marti MD, Bartoli MA, Arnaud L, Mancini J, Boudes A, Sarlon E, Thevenin B, Leroyer AS, Squarcioni C, Magnan PE, Dignat-George F, Sabatier F, Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol 2013 62 1436 1441. doi: 10.1016/j.jacc.2013.03.078.
65. Schiro A, Wilkinson FL, Weston R, Smyth JV, Serracino-Inglott F, Alexander MY, Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. Sci Rep 2015 5 16658. doi: 10.1038/srep16658.
66. Min PK, Kim JY, Chung KH, Lee BK, Cho M, Lee DL, Hong SY, Choi EY, Yoon YW, Hong BK, Rim SJ, Kwon HM, Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013 227 323 328. doi: 10.1016/j.atherosclerosis.2013.01.032.
67. Porto I, Biasucci LM, De Maria GL, Leone AM, Niccoli G, Burzotta F, Trani C, Tritarelli A, Vergallo R, Liuzzo G, Crea F, Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012 33 2928 2938. doi: 10.1093/eurheartj/ehs065.
68. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z, Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001 104 2649 2652
69. Tsiantoulas D, Perkmann T, Afonyushkin T, Mangold A, Prohaska TA, Papac-Milicevic N, Millischer V, Bartel C, Hörkkö S, Boulanger CM, Tsimikas S, Fischer MB, Witztum JL, Lang IM, Binder CJ, Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res 2015 56 440 448. doi: 10.1194/jlr.P054569.
70. Bi S, Wang C, Jin Y, Lv Z, Xing X, Lu Q, Correlation between serum exosome derived miR-208a and acute coronary syndrome. Int J Clin Exp Med 2015 8 4275 4280
71. Emanueli C, Shearn AI, Laftah A, Fiorentino F, Reeves BC, Beltrami C, Mumford A, Clayton A, Gurney M, Shantikumar S, Angelini GD, Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS One 2016 11 e0154274. doi: 10.1371/journal.pone.0154274.
72. Yellon DM, Davidson SM, Exosomes: nanoparticles involved in cardioprotection? Circ Res 2014 114 325 332. doi: 10.1161/CIRCRESAHA.113.300636.
73. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H, Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009 54 601 608. doi: 10.1016/j.jacc.2009.05.022.
74. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N, Circulating CD31+/annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011 32 2034 2041. doi: 10.1093/eurheartj/ehq478.
75. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y, Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009 28 1081 1086. doi: 10.1016/j.healun.2009.06.005.
76. Simak J, Gelderman MP, Yu H, Wright V, Baird AE, Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006 4 1296 1302. doi: 10.1111/j.1538-7836.2006.01911.x.
77. Kanhai DA, Visseren FL, van der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, Kappelle LJ, Uiterwaal CS, Lim SK, Sze SK, Pasterkamp G, de Kleijn DP, SMART Study Group Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol 2013 168 2358 2363. doi: 10.1016/j.ijcard.2013.01.231.
78. Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, Sinning JM, Vasa-Nicotera M, Nickenig G, Werner N, MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc 2014 3 e001249. doi: 10.1161/JAHA.114.001249.
79. de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, Rabelink TJ, van Zonneveld AJ, Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 2013 34 3451 3457. doi: 10.1093/eurheartj/eht007.
80. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M, Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012 60 290 299. doi: 10.1016/j.jacc.2012.03.056.
81. Rand ML, Wang H, Bang KW, Packham MA, Freedman J, Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 2006 4 1621 1623. doi: 10.1111/j.1538-7836.2006.02011.x.
82. Saunderson SC, Dunn AC, Crocker PR, McLellan AD, CD169 mediates the capture of exosomes in spleen and lymph node. Blood 2014 123 208 216. doi: 10.1182/blood-2013-03-489732.
83. Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y, Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 2013 165 77 84. doi: 10.1016/j.jbiotec.2013.03.013.
84. Willekens FL, Werre JM, Kruijt JK, Roerdinkholder-Stoelwinder B, Groenen-Döpp YA, van den Bos AG, Bosman GJ, van Berkel TJ, Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005 105 2141 2145. doi: 10.1182/blood-2004-04-1578.
85. Rank A, Nieuwland R, Crispin A, Grützner S, Iberer M, Toth B, Pihusch R, Clearance of platelet microparticles in vivo. Platelets 2011 22 111 116. doi: 10.3109/09537104.2010.520373.
86. Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, Nickenig G, Werner N, Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013 128 2026 2038. doi: 10.1161/CIRCULATIONAHA.113.001720.
87. Dasgupta SK, Le A, Chavakis T, Rumbaut RE, Thiagarajan P, Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 2012 125 1664 1672. doi: 10.1161/CIRCULATIONAHA.111.068833.
88. Yáñez-Mó M, Siljander PR, Andreu Z, Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015 4 27066. doi: 10.3402/jev.v4.27066.
89. Jansen F, Yang X, Hoyer FF, Paul K, Heiermann N, Becher MU, Abu Hussein N, Kebschull M, Bedorf J, Franklin BS, Latz E, Nickenig G, Werner N, Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol 2012 32 1925 1935. doi: 10.1161/ATVBAHA.112.253229.
90. Dasgupta SK, Abdel-Monem H, Niravath P, Le A, Bellera RV, Langlois K, Nagata S, Rumbaut RE, Thiagarajan P, Lactadherin and clearance of platelet-derived microvesicles. Blood 2009 113 1332 1339. doi: 10.1182/blood-2008-07-167148.
91. Al Faraj A, Gazeau F, Wilhelm C, Devue C, Guérin CL, Péchoux C, Paradis V, Clément O, Boulanger CM, Rautou PE, Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology 2012 263 169 178. doi: 10.1148/radiol.11111329.
92. Imai T, Takahashi Y, Nishikawa M, Kato K, Morishita M, Yamashita T, Matsumoto A, Charoenviriyakul C, Takakura Y, Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles 2015 4 26238. doi: 10.3402/jev.v4.26238.
93. Peinado H, Alečković M, Lavotshkin S, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012 18 883 891. doi: 10.1038/nm.2753.
94. Rana S, Yue S, Stadel D, Zöller M, Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 2012 44 1574 1584. doi: 10.1016/j.biocel.2012.06.018.
95. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S, Identification of a factor that links apoptotic cells to phagocytes. Nature 2002 417 182 187. doi: 10.1038/417182a.
96. Bank IE, Timmers L, Gijsberts CM, Zhang YN, Mosterd A, Wang JW, Chan MY, De Hoog V, Lim SK, Sze SK, Lam CS, De Kleijn DP, The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease. Expert Rev Mol Diagn 2015 15 1577 1588. doi: 10.1586/14737159.2015.1109450.
97. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T, Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost 2004 10 133 141
98. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T, Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 2005 19 551 557. doi: 10.1038/sj.jhh.1001863.
99. Nomura S, Shouzu A, Omoto S, Inami N, Shimazu T, Satoh D, Kajiura T, Yamada K, Urase F, Maeda Y, Iwasaka T, Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients. Blood Coagul Fibrinolysis 2009 20 440 447. doi: 10.1097/MBC.0b013e32832e0618.
100. Nomura S, Ozaki Y, Ikeda Y, Function and role of microparticles in various clinical settings. Thromb Res 2008 123 8 23. doi: 10.1016/j.thromres.2008.06.006.
101. Diamant M, Tushuizen ME, Abid-Hussein MN, Hau CM, Böing AN, Sturk A, Nieuwland R, Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemost 2008 100 489 497
102. Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, Dignat-George F, Anfosso F, Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006 108 1868 1876. doi: 10.1182/blood-2006-04-014175.
103. Tramontano AF, O'Leary J, Black AD, Muniyappa R, Cutaia MV, El-Sherif N, Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun 2004 320 34 38. doi: 10.1016/j.bbrc.2004.05.127.
104. Huang B, Cheng Y, Xie Q, Lin G, Wu Y, Feng Y, Gao J, Xu D, Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. Clin Cardiol 2012 35 125 130. doi: 10.1002/clc.21017.
105. Zu L, Ren C, Pan B, Zhou B, Zhou E, Niu C, Wang X, Zhao M, Gao W, Guo L, Zheng L, Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells. Int J Cardiol 2016 202 756 759. doi: 10.1016/j.ijcard.2015.10.035.
106. Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP, Pinheiro LF, Fonseca FA, Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy. Braz J Med Biol Res 2014 47 432 437. doi: 10.1590/1414-431X20143628
107. Almquist T, Mobarrez F, Jacobson SH, Wallén H, Hjemdahl P, Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant 2016 31 944 952. doi: 10.1093/ndt/gfv337.
108. Mobarrez F, Egberg N, Antovic J, Bröijersen A, Jörneskog G, Wallén H, Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res 2012 129 95 97. doi: 10.1016/j.thromres.2011.09.027.
109. Shimazu T, Inami N, Satoh D, Kajiura T, Yamada K, Iwasaka T, Nomura S, Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients. J Thromb Thrombolysis 2009 28 429 435. doi: 10.1007/s11239-008-0301-3.
110. Gerrits AJ, Koekman CA, Yildirim C, Nieuwland R, Akkerman JWN, Insulin inhibits tissue factor expression in monocytes. J Thromb Haemost 2009 7 198 205. doi: 10.1111/j.1538-7836.2008.03206.x.
111. Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S, Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases. Haemostasis 1999 29 255 261
112. Shouzu A, Nomura S, Omoto S, Hayakawa T, Nishikawa M, Iwasaka T, Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus. Clin Appl Thromb Hemost 2004 10 167 173
113. Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM, Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost 2003 1 2022 2030
114. Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Tedgui A, Freyssinet JM, Toti F, Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004 2 1118 1126. doi: 10.1111/j.1538-7836.2004.00805.x.
115. Judge HM, Buckland RJ, Sugidachi A, Jakubowski JA, Storey RF, The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses. Platelets 2008 19 125 133. doi: 10.1080/09537100701694144.
116. Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G, Altevogt P, Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 2007 107 563 571. doi: 10.1016/j.ygyno.2007.08.064.
117. Galindo-Hernandez O, Villegas-Comonfort S, Candanedo F, González-Vázquez MC, Chavez-Ocaña S, Jimenez-Villanueva X, Sierra-Martinez M, Salazar EP, Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients. Arch Med Res 2013 44 208 214. doi: 10.1016/j.arcmed.2013.03.002.
118. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T, Middeldorp JM, Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010 107 6328 6333. doi: 10.1073/pnas.0914843107.
119. Fujita Y, Araya J, Ochiya T, Extracellular vesicles in smoking-related lung diseases. Oncotarget 2015 6 43144 43145. doi: 10.18632/oncotarget.6556.
120. Badrnya S, Baumgartner R, Assinger A, Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost 2014 112 128 136. doi: 10.1160/TH13-11-0977.
121. Wahl P, Jansen F, Achtzehn S, Schmitz T, Bloch W, Mester J, Werner N, Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLoS One 2014 9 e96024. doi: 10.1371/journal.pone.0096024.
122. Yin M, Loyer X, Boulanger CM, Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol 2015 763 90 103. doi: 10.1016/j.ejphar.2015.06.047.
123. Nolan JP, Flow Cytometry of Extracellular Vesicles: Potential, Pitfalls, and Prospects 2001 Hoboken, NJ John Wiley & Sons, Inc
124. Verma M, Lam TK, Hebert E, Divi RL, Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clin Pathol 2015 15 6. doi: 10.1186/s12907-015-0005-5.
125. Lynch M, Barallobre-Barreiro J, Jahangiri M, Mayr M, Vascular proteomics in metabolic and cardiovascular diseases. J Intern Med 2016 280 325 338. doi: 10.1111/joim.12486.
126. Kishore R, Garikipati VN, Gumpert A, Tiny shuttles for information transfer: exosomes in cardiac health and disease. J Cardiovasc Transl Res 2016 9 169 175. doi: 10.1007/s12265-016-9682-4.
127. Tomaniak M, Gasecka A, Filipiak KJ, Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring-A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application. Int J Cardiol 2017 226 93 102. doi: 10.1016/j.ijcard.2016.10.007.
128. Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 2012 109 E1695 E1704. doi: 10.1073/pnas.1201516109.
129. Cheng CJ, Saltzman WM, Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing. Mol Pharm 2012 9 1481 1488. doi: 10.1021/mp300081s.
130. Chen Y, Zhu X, Zhang X, Liu B, Huang L, Nanoparticles modified with tumor-Targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 2010 18 1650 1656. doi: 10.1038/mt.2010.136.
131. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, Sahoo S, Tahara H, Wauben MH, Witwer KW, Théry C, Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014 3 26913. doi:10.3402/jev.v3.26913.
132. Hill AF, Pegtel DM, Lambertz U, Leonardi T, O'Driscoll L, Pluchino S, Ter-Ovanesyan D, Nolte-'t Hoen ENM, ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J Extracell Vesicles 2013 2. doi: 10.3402/jev.v2i0.22859.